IL17A and psoriasis: Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases driven predominantly by dysregulation of the IL-23/Th17 axis, with central contributions from IL-23, IL-17A/F, and TNF-α [1,2,3,4,5].